Article
Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug target
15 Jun 2023
Abstract excerpt
Uveal melanoma (UM) has a high risk to progress to metastatic disease with a median survival of 3.9 months after metastases detection, as metastatic UM responds poorly to conventional and targeted chemotherapy and is largely refractory to immunotherapy. Here, we present a patient-derived zebrafish UM xenograft model mimicking metastatic UM. Cells isolated from Xmm66 spheroids derived from metastatic UM patient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
